Partnership to Support Real-World Evidence Studies and Fuel Development of Gene Therapy for Lesch-Nyhan Disease AllStripes’ Patient-Centric Rare Disease Platform Expands to 20 Rare Diseases…

TORRANCE, Calif.–(BUSINESS WIRE)–Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and…

FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for…

ASAP Developed Using FDA-Recommended Active Safety Surveillance Approach First-of-its-kind cloud-based capability leverages RWD for pharmacovigilance Complements existing spontaneous safety…

– Promising findings featuring XL092, Exelixis’ next-generation oral tyrosine kinase inhibitor, recently presented at the 32nd EORTC-NCI-AACR (ENA) Symposium – ALAMEDA, Calif.–(BUSINESS…

Innovation can help address screening backlog due to COVID-19 pandemic by streamlining breast imaging reading process MARLBOROUGH, Mass.–(BUSINESS WIRE)–#COVID19–Hologic,…

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–James Aggen, PhD has joined Circle Pharma as its Vice President of Medicinal Chemistry and will lead Circle’s chemistry team in its…

HENDERSON, Nev.–(BUSINESS WIRE)–United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp, a patented Oxidized Regenerated…

Virtual screening team honored for deploying innovative technology during pandemic HORSHAM, Pa.–(BUSINESS WIRE)–Accelerated Enrollment Solutions (AES), a business of PPD, Inc.…

Leading investors and experts to provide insights into business challenges and tech solutions in the shadow of COVID-19 JERUSALEM & NEW YORK–(BUSINESS WIRE)–OurCrowd, Israel’s…